BR8506785A - Processo e aparelho para o tratamento terapeutico efetivo de um animal vivo - Google Patents
Processo e aparelho para o tratamento terapeutico efetivo de um animal vivoInfo
- Publication number
- BR8506785A BR8506785A BR8506785A BR8506785A BR8506785A BR 8506785 A BR8506785 A BR 8506785A BR 8506785 A BR8506785 A BR 8506785A BR 8506785 A BR8506785 A BR 8506785A BR 8506785 A BR8506785 A BR 8506785A
- Authority
- BR
- Brazil
- Prior art keywords
- therapeutic treatment
- effective therapeutic
- live animal
- live
- animal
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/626,400 US4747825A (en) | 1984-06-29 | 1984-06-29 | Apparatus and methodology for pulsed administration of growth promoting agents |
PCT/US1985/001229 WO1986000233A1 (en) | 1984-06-29 | 1985-06-27 | Apparatus and methodology for pulsed administration of growth promoting agents |
Publications (1)
Publication Number | Publication Date |
---|---|
BR8506785A true BR8506785A (pt) | 1986-11-25 |
Family
ID=24510242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR8506785A BR8506785A (pt) | 1984-06-29 | 1985-06-27 | Processo e aparelho para o tratamento terapeutico efetivo de um animal vivo |
Country Status (16)
Country | Link |
---|---|
US (1) | US4747825A (pt) |
EP (1) | EP0190199A4 (pt) |
JP (1) | JPS61502519A (pt) |
AU (1) | AU4605385A (pt) |
BE (1) | BE902783A (pt) |
BR (1) | BR8506785A (pt) |
DK (1) | DK294685A (pt) |
FI (1) | FI852516L (pt) |
IL (1) | IL75671A0 (pt) |
MW (1) | MW686A1 (pt) |
NO (1) | NO852603L (pt) |
OA (1) | OA08214A (pt) |
PT (1) | PT80738B (pt) |
RO (1) | RO95012A (pt) |
WO (1) | WO1986000233A1 (pt) |
ZA (1) | ZA854916B (pt) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5089472A (en) * | 1988-01-26 | 1992-02-18 | Laboratorios Serono S.A. | Use of growth hormone releasing factor for improving mental function |
US5065748A (en) * | 1989-11-14 | 1991-11-19 | University Of South Florida | Method of diagnosing growth hormone disorders employing somatostatin and growth hormone releasing hormone |
US5065747A (en) * | 1989-11-21 | 1991-11-19 | University Of South Florida | Method for improving the accuracy of diagnosis of growth hormone deficiency |
US5428013A (en) * | 1991-01-04 | 1995-06-27 | Mugica; Jesus D. | Differential diagnosis and treatment of the states of growth hormone insufficiency (or deficiency) with an alpha-2-adrenergic agonist and a growth hormone releasing peptide |
US7910624B1 (en) | 1995-03-03 | 2011-03-22 | The Trustees Of Boston University | Compositions for the treatment of blood disorders |
EP0731712A4 (en) * | 1993-10-29 | 2005-11-09 | Univ Boston | PHYSIOLOGICAL STABILIZED BUTTERIC ACID PREPARATIONS, AND BUTTERIC ACIDS AND DERIVATIVES AS ANTINEOPLASTIC ACTIVE SUBSTANCE |
JPH10511095A (ja) * | 1994-12-19 | 1998-10-27 | ベス イスラエル ディーコネス メディカル センター インコーポレイテッド | 副甲状腺ホルモン又はその作動薬の低用量継続投与 |
US6403647B1 (en) | 1996-07-26 | 2002-06-11 | Susan P. Perrine | Pulsed administration of compositions for the treatment of blood disorders |
US5939456A (en) * | 1996-07-26 | 1999-08-17 | Perrine; Susan P. | Pulsed administration of compositions for the treatment of blood disorders |
EP1886677A1 (en) | 1996-07-26 | 2008-02-13 | Susan P. Perrine | Use of an inducing agent for the treatment of blood, viral and cellular disorders |
ES2146530B1 (es) * | 1997-12-26 | 2001-04-16 | Consejo Superior Investigacion | Utilizacion del factor de crecimiento igf-i en la fabricacion de composiciones utiles en el tratamiento de la ataxia cerebelar. |
CA2324426A1 (en) * | 1998-02-11 | 1999-08-19 | Douglas V. Faller | Compositions and methods for the treatment of cystic fibrosis |
DE60332358D1 (de) * | 2002-09-09 | 2010-06-10 | Hanall Pharmaceutical Co Ltd | Protease-resistente modifizierte interferon alpha polypeptide |
US7998930B2 (en) | 2004-11-04 | 2011-08-16 | Hanall Biopharma Co., Ltd. | Modified growth hormones |
WO2010105112A1 (en) * | 2009-03-11 | 2010-09-16 | Hemaquest Pharmaceuticals, Inc. | Detection of short-chain fatty acids in biological samples |
WO2011014775A1 (en) | 2009-07-31 | 2011-02-03 | The Brigham And Women's Hospital, Inc. | Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses |
WO2011038224A1 (en) | 2009-09-24 | 2011-03-31 | Trustees Of Boston University | Methods for treating viral disorders |
WO2011072086A1 (en) | 2009-12-08 | 2011-06-16 | Hemaquest Pharmaceuticals, Inc. | Methods and low dose regimens for treating red blood cell disorders |
US20110245154A1 (en) | 2010-03-11 | 2011-10-06 | Hemaquest Pharmaceuticals, Inc. | Methods and Compositions for Treating Viral or Virally-Induced Conditions |
WO2012106281A2 (en) | 2011-01-31 | 2012-08-09 | The General Hospital Corporation | Multimodal trail molecules and uses in cellular therapies |
US9585930B2 (en) | 2011-03-20 | 2017-03-07 | Trustees Of Boston University | Therapeutic agent for emphysema and COPD |
US9480696B2 (en) | 2011-05-04 | 2016-11-01 | Trustees Of Boston University | Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria |
US20140227293A1 (en) | 2011-06-30 | 2014-08-14 | Trustees Of Boston University | Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1) |
EP2766041B1 (en) | 2011-10-12 | 2018-12-05 | Children's Medical Center Corporation | Combinatorial compositions and methods of treating hemoglobinopathies |
US9243037B2 (en) | 2011-11-10 | 2016-01-26 | Trustees Of Boston College | Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity |
US9173884B2 (en) | 2011-11-30 | 2015-11-03 | Trustees Of Boston College | Inhibitors of phosphodiesterase 11 (PDE11) |
US10513540B2 (en) | 2012-07-31 | 2019-12-24 | The Brigham And Women's Hospital, Inc. | Modulation of the immune response |
WO2014035474A1 (en) | 2012-08-30 | 2014-03-06 | The General Hospital Corporation | Compositions and methods for treating cancer |
BR112015008118A2 (pt) | 2012-10-12 | 2017-12-05 | Brigham & Womens Hospital Inc | reforço da resposta imune |
US20150366890A1 (en) | 2013-02-25 | 2015-12-24 | Trustees Of Boston University | Compositions and methods for treating fungal infections |
EP3036226B1 (en) | 2013-08-22 | 2020-01-08 | The General Hospital Corporation | Inhibitors of human 12/15-lipoxygenase |
EP3038625A4 (en) | 2013-08-29 | 2017-08-23 | Trustees of Boston University | Intermediate metabolism products to potentiate aminoglycoside antibiotics in bacterial infections |
ES2909014T3 (es) | 2013-11-26 | 2022-05-04 | Brigham & Womens Hospital Inc | Composiciones y métodos para modular una respuesta inmunitaria |
WO2015089321A2 (en) | 2013-12-11 | 2015-06-18 | The General Hospital Corporation | Use of mullerian inhibiting substance (mis) proteins for contraception and ovarian reserve preservation |
US20170107300A1 (en) | 2014-03-21 | 2017-04-20 | The Brigham And Women's Hospital, Inc. | Methods and compositions for treatment of immune-related diseases or disorders and/or therapy monitoring |
WO2015164364A2 (en) | 2014-04-25 | 2015-10-29 | The Brigham And Women's Hospital, Inc. | Methods to manipulate alpha-fetoprotein (afp) |
EP3134733B1 (en) | 2014-04-25 | 2020-10-14 | The Brigham and Women's Hospital, Inc. | Assay and method for treating subjects with immune-mediated diseases |
WO2016044707A1 (en) | 2014-09-18 | 2016-03-24 | Cedars-Sinai Medical Center | Compositions and methods for treating fibrosis |
AU2016206682B2 (en) | 2015-01-14 | 2021-11-11 | The Brigham And Women's Hospital, Inc. | Treatment of cancer with anti-LAP monoclonal antibodies |
WO2016172479A1 (en) | 2015-04-22 | 2016-10-27 | Cedars-Sinai Medical Center | Enterically delivered bitter oligopeptides for the treatment for type 2 diabetes |
WO2016196664A1 (en) | 2015-06-01 | 2016-12-08 | Cedars-Sinai Medical Center | Methods and use of compounds that bind to rela of nf-kb |
CN116712552A (zh) | 2015-06-19 | 2023-09-08 | 波士顿大学托管委员会 | 用于治疗疱疹病毒诱导的病况的方法和组合物 |
MX2018001075A (es) | 2015-07-28 | 2019-04-15 | Vyome Therapeutics Ltd | Agentes terapeuticos y profilacticos antibacterianos. |
WO2017058828A1 (en) | 2015-09-28 | 2017-04-06 | Children's Hospital Los Angeles | Methods for treating diseases mediated by erbb4-positive pro-inflammatory macrophages |
US20190255107A1 (en) | 2015-10-09 | 2019-08-22 | The Brigham And Women's Hospital, Inc. | Modulation of novel immune checkpoint targets |
US20200016202A1 (en) | 2016-10-07 | 2020-01-16 | The Brigham And Women's Hospital, Inc. | Modulation of novel immune checkpoint targets |
EP3752532A1 (en) | 2018-02-12 | 2020-12-23 | Diabetes-Free, Inc. | Improved antagonistic anti-human cd40 monoclonal antibodies |
WO2020102454A1 (en) | 2018-11-13 | 2020-05-22 | Regents Of The University Of Minnesota | Cd40 targeted peptides and uses thereof |
SG11202113215UA (en) | 2019-05-31 | 2021-12-30 | Viracta Subsidiary Inc | Methods of treating virally associated cancers with histone deacetylase inhibitors |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3498228A (en) * | 1967-05-01 | 1970-03-03 | Charles A Blumle | Portable infusion pump |
US3559644A (en) * | 1967-12-14 | 1971-02-02 | Robert F Shaw | Liquid infusion apparatus |
US3809871A (en) * | 1972-12-01 | 1974-05-07 | Nasa | Programmable physiological infusion |
US4273122A (en) * | 1976-11-12 | 1981-06-16 | Whitney Douglass G | Self contained powered injection system |
US4313439A (en) * | 1980-03-24 | 1982-02-02 | Biotek, Inc. | Automated, spring-powered medicament infusion system |
DE3015777A1 (de) * | 1980-04-24 | 1981-10-29 | Ferring Arzneimittel Gmbh, 2300 Kiel | Vorrichtung zur intermittierenden pulsatorischen applikation von fluessigen arzneimitteln |
US4306553A (en) * | 1980-07-22 | 1981-12-22 | The Regents Of The University Of Minnesota | Method of maintaining the fluidity of hormone solutions for parenteral administration |
US4517181A (en) * | 1982-09-15 | 1985-05-14 | The Salk Institute For Biological Studies | Mammalian PGRF |
US4529595A (en) * | 1983-01-13 | 1985-07-16 | The Salk Institute For Biological Studies | GRF Analogs |
-
1984
- 1984-06-29 US US06/626,400 patent/US4747825A/en not_active Expired - Lifetime
-
1985
- 1985-06-26 FI FI852516A patent/FI852516L/fi not_active Application Discontinuation
- 1985-06-27 WO PCT/US1985/001229 patent/WO1986000233A1/en not_active Application Discontinuation
- 1985-06-27 JP JP60503052A patent/JPS61502519A/ja active Pending
- 1985-06-27 BR BR8506785A patent/BR8506785A/pt unknown
- 1985-06-27 AU AU46053/85A patent/AU4605385A/en not_active Abandoned
- 1985-06-27 EP EP19850903566 patent/EP0190199A4/en not_active Withdrawn
- 1985-06-28 ZA ZA854916A patent/ZA854916B/xx unknown
- 1985-06-28 PT PT80738A patent/PT80738B/pt unknown
- 1985-06-28 IL IL75671A patent/IL75671A0/xx unknown
- 1985-06-28 NO NO852603A patent/NO852603L/no unknown
- 1985-06-28 DK DK294685A patent/DK294685A/da not_active Application Discontinuation
- 1985-06-28 BE BE0/215282A patent/BE902783A/fr not_active IP Right Cessation
-
1986
- 1986-01-31 MW MW6/86A patent/MW686A1/xx unknown
- 1986-02-27 RO RO86122377A patent/RO95012A/ro unknown
- 1986-02-28 OA OA58797A patent/OA08214A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO1986000233A1 (en) | 1986-01-16 |
PT80738B (en) | 1986-12-11 |
EP0190199A1 (en) | 1986-08-13 |
MW686A1 (en) | 1987-03-11 |
FI852516A0 (fi) | 1985-06-26 |
AU4605385A (en) | 1986-01-24 |
ZA854916B (en) | 1986-02-26 |
FI852516L (fi) | 1985-12-30 |
EP0190199A4 (en) | 1987-12-01 |
OA08214A (en) | 1987-10-30 |
IL75671A0 (en) | 1985-10-31 |
US4747825A (en) | 1988-05-31 |
JPS61502519A (ja) | 1986-11-06 |
DK294685A (da) | 1985-12-30 |
BE902783A (fr) | 1985-10-16 |
PT80738A (en) | 1985-07-01 |
DK294685D0 (da) | 1985-06-28 |
RO95012A (ro) | 1988-09-15 |
NO852603L (no) | 1985-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR8506785A (pt) | Processo e aparelho para o tratamento terapeutico efetivo de um animal vivo | |
BR8505605A (pt) | Processo para tratar condicoes externas do olho humano e implante para o canaliculo do olho humano | |
PT88200A (pt) | Processo para a preparacao de uma composicao para o tratamento da pele | |
BR8506419A (pt) | Processo e aparelho para o tratamento termico de um trilho | |
BR8305329A (pt) | Atadura e processo para tratar dor e/ou inflamacao | |
BR8109030A (pt) | Processo e composicao para o tratamento do acne | |
PT88972A (pt) | Processo para a preparacao de uma composicao util para o tratamento do cabelo ou da pele | |
BR8905555A (pt) | Aparelho e processo para suportar corpo humano | |
BR8801105A (pt) | Composicoes para cuidados da pele e metodo para o tratamento da pele | |
BR8707572A (pt) | Composicao para tratamento de pele resistente a umidade | |
ES544066A0 (es) | Procedimiento de preparar agentes de tratamiento de fibras queratinosas y metodo de aplicacion correspondiente | |
PT82608A (pt) | Processo para o tratamento de sementes e sementes assim tratadas | |
BR8806640A (pt) | Granulados,processo para tratamento fitossanitario e processo para preparacao de granulados | |
BR8700683A (pt) | Processo de distribuicao de material de tecido flexivel e distribuidor para rolos de material de tecido flexivel | |
BR8506970A (pt) | Processo e aparelho para o tratamento do aparelho respiratorio | |
BR8707251A (pt) | Processo e aparelho para o tratamento compressivo de tecido | |
BR9002081A (pt) | Processo e aparelho para o tratamento de detritos organicos | |
PT90176A (pt) | Processo para a preparacao de um agente de tratamento de gado equideo | |
KR910003683B1 (en) | Agent and method for treating animal hair fiber | |
BR8804808A (pt) | Dispositivo e processo para tratamento de doencas gengivais | |
PT89604B (pt) | Processo para o tratamento de peles de animais relacionado com a producao de coiros e aparelho para a sua realizacao | |
BR8603350A (pt) | Metodo e equipamento para o tratamento de couros em tambor | |
IL74637A0 (en) | A pharmaceutical composition comprising a benzimidazole derivative for treating skin diseases in aquatic animals and a method of treatment thereof | |
BR9304018A (pt) | Processo para o tratamento agroquimico de pastos | |
BR8806754A (pt) | Metodo e aparelho para tratamento de materiais texteis alongados |